Virtus Fund Advisers, LLC Adma Biologics, Inc. Transaction History
Virtus Fund Advisers, LLC
- $25 Million
- Q2 2024
A detailed history of Virtus Fund Advisers, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 14,058 shares of ADMA stock, worth $229,285. This represents 0.63% of its overall portfolio holdings.
Number of Shares
14,058
Previous 13,345
5.34%
Holding current value
$229,285
Previous $88,000
78.41%
% of portfolio
0.63%
Previous 0.31%
Shares
4 transactions
Others Institutions Holding ADMA
# of Institutions
281Shares Held
179MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$304 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$237 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$215 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$146 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$131 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.2B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...